Research Connect

TL;DR

The most useful techniques and how machine learning can promote data-driven decision making in drug discovery and development are discussed and major hurdles in the field are highlighted, such as the required data characteristics for applying ML.

Abstract

Authors

J. Vamathevan

1 Paper

Dominic Clark

1 Paper

P. Czodrowski

1 Paper

I. Dunham

1 Paper

Edgardo Ferran

1 Paper

George Lee

1 Paper

Bin Li

1 Paper

A. Madabhushi

1 Paper

Parantu K. Shah

1 Paper

M. Spitzer

1 Paper

Shanrong Zhao

1 Paper

TL;DR

Abstract

Authors

References121 items

Deep Learning

Publisher's Note

Molecular de-novo design through deep reinforcement learning

The rise of deep learning in drug discovery.

Planning chemical syntheses with deep neural networks and symbolic AI

druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico.

Deep Neural Nets as a Method for Quantitative Structure-Activity Relationships

enchmark for molecular machine learning †

Dropout: a simple way to prevent neural networks from overfitting

VASC: Dimension Reduction and Visualization of Single-cell RNA-seq Data by Deep Variational Autoencoder

Deep Learning-A Technology With the Potential to Transform Health Care.

Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning

Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non–Small Cell Lung Cancer

Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission

Machine Learning on Human Muscle Transcriptomic Data for Biomarker Discovery and Tissue-Specific Drug Target Identification

Nuclear shape and orientation features from H&E images predict survival in early-stage estrogen receptor-positive breast cancers

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations

Biomarkers as drug development tools: discovery, validation, qualification and use

Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease

Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer

Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images.

A deep-learning classifier identifies patients with clinical heart failure using whole-slide images of H&E tissue

Transcriptional regulatory networks underlying gene expression changes in Huntington's disease

Deep learning based tissue analysis predicts outcome in colorectal cancer

Artificial intelligence faces reproducibility crisis.

Systematic interrogation of diverse Omic data reveals interpretable, robust, and generalizable transcriptomic features of clinically successful therapeutic targets

Deep convolutional neural networks for automatic classification of gastric carcinoma using whole slide images in digital histopathology

Open source machine-learning algorithms for the prediction of optimal cancer drug therapies

MR fingerprinting Deep RecOnstruction NEtwork (DRONE)

Dhaka: Variational Autoencoder for Unmasking Tumor Heterogeneity from Single Cell Genomic Data

Interpretable dimensionality reduction of single cell transcriptome data with deep generative models

Extracting a Biologically Relevant Latent Space from Cancer Transcriptomes with Variational Autoencoders

An oral cavity squamous cell carcinoma quantitative histomorphometric-based image classifier of nuclear morphology can risk stratify patients for disease-specific survival

Is Multitask Deep Learning Practical for Pharma?

Defining a Cancer Dependency Map

In silico prediction of novel therapeutic targets using gene–disease association data

A multi‐scale convolutional neural network for phenotyping high‐content cellular images

Abstract 662: The differential association of PD-1, PD-L1, and CD8+ cells with response to pembrolizumab and presence of Merkel cell polyomavirus (MCPyV) in patients with Merkel cell carcinoma (MCC)

IntegratedMRF: random forest‐based framework for integrating prediction from different data types

Bridging the translational innovation gap through good biomarker practice

A novel framework for the identification of drug target proteins: Combining stacked auto-encoders with a biased support vector machine

Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent

A machine-learning heuristic to improve gene score prediction of polygenic traits

Maximum entropy methods for extracting the learned features of deep neural networks

Low-Dose CT With a Residual Encoder-Decoder Convolutional Neural Network

Integrative deep models for alternative splicing

An analysis of disease-gene relationship from Medline abstracts by DigSee

Deep Learning for Classification of Colorectal Polyps on Whole-slide Images

Open Targets: a platform for therapeutic target identification and validation

Systematic Analysis of Drug Targets Confirms Expression in Disease-Relevant Tissues

Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer

A Landscape of Pharmacogenomic Interactions in Cancer

Deep learning for computational biology

Visualization and analysis of single-cell RNA-seq data by kernel-based similarity learning

Automated Tubule Nuclei Quantification and Correlation with Oncotype DX risk categories in ER+ Breast Cancer Whole Slide Images

A new view of transcriptome complexity and regulation through the lens of local splicing variations

ADAGE-Based Integration of Publicly Available Pseudomonas aeruginosa Gene Expression Data with Denoising Autoencoders Illuminates Microbe-Host Interactions

Deep learning for digital pathology image analysis: A comprehensive tutorial with selected use cases

Antibody-supervised deep learning for quantification of tumor-infiltrating immune cells in hematoxylin and eosin stained breast cancer samples

Sparse group factor analysis for biclustering of multiple data sources

Prediction of Druggable Proteins Using Machine Learning and Systems Biology: A Mini-Review

Development of a Drug-Response Modeling Framework to Identify Cell Line Derived Translational Biomarkers That Can Predict Treatment Outcome to Erlotinib or Sorafenib

ZIFA: Dimensionality reduction for zero-inflated single-cell gene expression analysis

Improving Drug Sensitivity Prediction Using Different Types of Data

A systematic approach to identify novel cancer drug targets using machine learning, inhibitor design and high-throughput screening

Extraction of relations between genes and diseases from text and large-scale data analysis: implications for translational research

Deep learning of the tissue-regulated splicing code

A community effort to assess and improve drug sensitivity prediction algorithms

Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival

The BATTLE trial: personalizing therapy for lung cancer.

A machine learning approach for genome-wide prediction of morbid and druggable human genes based on systems-level data

Properties and identification of human protein drug targets

Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myélome.

Prediction of potential drug targets based on simple sequence properties

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib.

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.